We have located links that may give you full text access.
Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumours.
Neuroendocrinology 2018 October 6
BACKGROUND: The prevalence of small intestine neuroendocrine tumours (SI-NETs) is increasing. Disease progression is often slow and treatment options and long-term survival rates have improved, but little is known about health-related quality of life (HRQoL) in these patients. <br>Objective: To assess HRQoL and its predictors in SI-NET patients receiving contemporary treatments. <br>Methods: We measured HRQoL with 15D and SF-36 questionnaires in 134 SI-NET patients and compared the 15D results to those of age- and gender-standardized general population (n = 1153). In the patients, we studied impact of treatments, Ki67, liver metastases, circulating tumour markers, comorbidities and/or socioeconomic factors on HRQoL with linear regression analysis. <br>Results: Mean disease duration of the patients was 81 (4-468) months, 91% had metastatic disease and 79% received somatostatin analog treatment. Hepatic tumour load was 0% in 44.8%, <10-25% in 44.0%, and >25% in 11.2%, respectively. Mean fP-CgA and S-5HIAA concentrations were 15 (1.3-250) nmol/l and 344 (24-7470) nmol/l, respectively. Overall HRQoL was significantly impaired in patients compared to controls (15D scores 0.864±0.105 vs 0.905±0.028, p<0.001). SI-NET patients scored worse on 9 of 15 dimensions (sleep, excretion (ie bladder and bowel function), depression, distress, vitality, sexual activity (p< 0.001), breathing, usual activities, and discomfort and symptoms (p< 0.01-0.05). SF-36 scores were impaired and highly correlated with 15D scores (p<0.001). HRQoL was impaired in patients with (n=85) compared to patients without (n=49) impaired excretion (0.828 vs 0.933, p<0.001). In the patient group, number of medications predicted impaired HRQoL. <br>Conclusions: Despite contemporary treatments, SI-NET patients have severely impaired HRQoL, including diarrhea, sleep, depression, vitality and sexual activity. <br>.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app